1. Arlen, M., Hollinshead, A. C., and Scherrer, J., 1977, Tumor-specific immunity in patients with malignant melanoma, Surg. Forum
27: 168–169.
2. Carey, T. E., Lloyd, K. O., Takahashi, T., Travassos, L. R., and Old, L. J., 1979, AU cell-surface antigen in human malignant melanoma: Solubilization and partial characterization, Proc. Natl. Acad. Sci. U.S.A.
76(6): 2898–2902.
3. Carrel, S., Accolla, R. S., Carmagnola, A. L., and Mach, J.-P., 1980, Common human melanoma-associated antigen(s) detected by monoclonal antibodies, Cancer Res. 40: 2523–2528.
4. Char, D. V., Hollinshead, A. C., Cogan, D. G., Ballantine, R. J., Hogan, M. J., and Herberman, R. B., 1974, Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma, N. Engl. J. Med.
291: 274–277.
5. Char, D. V., Hollinshead, A. C., and Herberman, R. B., 1977, Skin tests with soluble melanoma antigens in patients with choroidal tumors, Cancer
40: 1650–1654.